Bilateral septic cavernous sinus thrombosis, congestive orbitopathy, and ischemic optic neuropathy

Can J Ophthalmol. 2016 Apr;51(2):e75-7. doi: 10.1016/j.jcjo.2015.12.007.

Authors

Pari N Shams¹, Bruno Policeni², Keith D Carter³, Erin Shriver³, Matthew J Thurtell³

Affiliations

¹ Moorfields Eye Hospital, Adnexal Service, London, United Kingdom. Electronic address: pari.shams@gmail.com.
² University of Iowa, Iowa City, Iowa.
³ University of Iowa Hospitals and Clinics, Iowa City, Iowa.

PMID: 27085286
DOI: 10.1016/j.jcjo.2015.12.007

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anti-Infective Agents / therapeutic use
Anticoagulants / therapeutic use
Bacteremia / diagnosis
Bacteremia / drug therapy
Bacteremia / microbiology*
Cavernous Sinus Thrombosis / diagnosis
Cavernous Sinus Thrombosis / drug therapy
Cavernous Sinus Thrombosis / microbiology*
Drug Therapy, Combination
Eye Infections, Bacterial / diagnosis
Eye Infections, Bacterial / drug therapy
Eye Infections, Bacterial / microbiology*
Female
Glucocorticoids / therapeutic use
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Magnetic Resonance Imaging
Methylprednisolone / therapeutic use
Metronidazole / therapeutic use
Ocular Motility Disorders / diagnosis
Ocular Motility Disorders / drug therapy
Ocular Motility Disorders / microbiology*
Optic Neuropathy, Ischemic / diagnosis
Optic Neuropathy, Ischemic / drug therapy
Optic Neuropathy, Ischemic / microbiology*
Streptococcal Infections / diagnosis
Streptococcal Infections / drug therapy
Streptococcal Infections / microbiology*
Streptococcus anginosus / isolation & purification*
Tomography, X-Ray Computed

Substances

Anti-Infective Agents
Anticoagulants
Glucocorticoids
Heparin, Low-Molecular-Weight
Metronidazole
Methylprednisolone